The effect of a cinnamon-, chromium- and magnesium-formulated honey on glycaemic control, weight loss and lipid parameters in type 2 diabetes: an open-label cross-over randomised controlled trial

Glycaemic Control ◽

Controlled Trial ◽

Open Label ◽

Randomised Controlled ◽

Lipid Parameters

Dietary carbohydrate restriction augments weight loss-induced improvements in glycaemic control and liver fat in individuals with type 2 diabetes: a randomised controlled trial

Diabetologia ◽

10.1007/s00125-021-05628-8 ◽

2022 ◽

Author(s):

Mads N. Thomsen ◽

Mads J. Skytte ◽

Amirsalar Samkani ◽

Martin H. Carl ◽

Philip Weber ◽

...

Keyword(s):

Type 2 Diabetes ◽

Weight Loss ◽

Glycaemic Control ◽

Controlled Trial ◽

Liver Fat ◽

Carbohydrate Restriction ◽

Dietary Carbohydrate ◽

Unsupervised high-intensity interval training improves glycaemic control but not cardiovascular autonomic function in type 2 diabetes patients: A randomised controlled trial

Diabetes and Vascular Disease Research ◽

10.1177/1479164118816223 ◽

2018 ◽

Vol 16 (1) ◽

pp. 69-76 ◽

Cited By ~ 2

Author(s):

Sophie Cassidy ◽

Vivek Vaidya ◽

David Houghton ◽

Pawel Zalewski ◽

Jelena P Seferovic ◽

...

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Autonomic Function ◽

Controlled Trial ◽

Interval Training ◽

High Intensity Interval Training ◽

High Intensity Interval ◽

Review for "Efficacy of two telemonitoring systems to improve glycaemic control during basal insulin initiation in patients with type 2 diabetes: The TeleDiab‐2 randomised controlled trial"

10.1111/dom.13806/v1/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Glycaemic Control ◽

Basal Insulin ◽

Controlled Trial ◽

Insulin Initiation ◽

Review for "Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: results of a multicentre, open‐label, randomised controlled trial (BEYOND VII)"

10.1111/dom.13967/v1/review6 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Chinese Patients ◽

Open Label ◽

Starting Dose ◽

Review for "Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: results of a multicentre, open‐label, randomised controlled trial (BEYOND VII)"

10.1111/dom.13967/v1/review4 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Chinese Patients ◽

Open Label ◽

Starting Dose ◽

Improving glycaemic control self-efficacy and glycaemic control behaviour in Chinese patients with Type 2 diabetes mellitus: randomised controlled trial

Journal of Clinical Nursing ◽

10.1111/j.1365-2702.2009.03040.x ◽

2010 ◽

Vol 19 (3-4) ◽

pp. 398-404 ◽

Cited By ~ 42

Author(s):

Qifang Shi ◽

Sharon K Ostwald ◽

Shaopeng Wang

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Glycaemic Control ◽

Controlled Trial ◽

Chinese Patients ◽

Randomised Controlled ◽

Control Behaviour

The DiGEM trial protocol – a randomised controlled trial to determine the effect on glycaemic control of different strategies of blood glucose self-monitoring in people with type 2 diabetes [ISRCTN47464659]

BMC Family Practice ◽

10.1186/1471-2296-6-25 ◽

2005 ◽

Vol 6 (1) ◽

Cited By ~ 25

Author(s):

Andrew Farmer ◽

Alisha Wade ◽

David P French ◽

Elizabeth Goyder ◽

Ann Louise Kinmonth ◽

...

Keyword(s):

Type 2 Diabetes ◽

Blood Glucose ◽

Glycaemic Control ◽

Controlled Trial ◽

Trial Protocol ◽

Self Monitoring ◽

Blood Glucose Self Monitoring ◽

Durability of insulin degludec plus liraglutide versus insulin glargine U100 as initial injectable therapy in type 2 diabetes (DUAL VIII): a multicentre, open-label, phase 3b, randomised controlled trial

The Lancet Diabetes & Endocrinology ◽

10.1016/s2213-8587(19)30184-6 ◽

2019 ◽

Vol 7 (8) ◽

pp. 596-605 ◽

Cited By ~ 15

Author(s):

Vanita R Aroda ◽

Guillermo González-Galvez ◽

Randi Grøn ◽

Natalie Halladin ◽

Martin Haluzík ◽

...

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Insulin Degludec ◽

Open Label ◽

Open Label Phase ◽

Review for "Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: results of a multicentre, open‐label, randomised controlled trial (BEYOND VII)"

10.1111/dom.13967/v2/review2 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Chinese Patients ◽

Open Label ◽

Starting Dose ◽

Review for "Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: results of a multicentre, open‐label, randomised controlled trial (BEYOND VII)"

10.1111/dom.13967/v2/review1 ◽

2019 ◽

Keyword(s):

Type 2 Diabetes ◽

Insulin Glargine ◽

Controlled Trial ◽

Chinese Patients ◽

Open Label ◽

Starting Dose ◽